Evidence map›Paper›PMID 32164672›Full record

ArticleBMC palliative care2020

First referral to an integrated onco-palliative care program: a retrospective analysis of its timing.

Claire Barth, Isabelle Colombet, Vincent Montheil, Olivier Huillard, Pascaline Boudou-Rouquette, Camille Tlemsani, Jérôme Alexandre, François Goldwasser, Pascale Vinant

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC palliative care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. A Bibliometric Analysis and Visualization of Decision Support Systems for Healthcare Referral Strategies.International journal of environmental research and public health · 2022
    Pooled it
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Duration of palliative care involvement and immunotherapy treatment near the end of life among patients with cancer who died in-hospital.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Claire BarthUnité Mobile de Soins Palliatifs, Hôpital Cochin, AP-HP Centre, Paris, France.
Isabelle ColombetUnité Mobile de Soins Palliatifs, Hôpital Cochin, AP-HP Centre, Paris, France. isabelle.colombet@aphp.fr.ORCID http://orcid.org/0000-0002-8721-1526
Vincent MontheilUnité Mobile de Soins Palliatifs, Hôpital Cochin, AP-HP Centre, Paris, France.
Olivier HuillardOncologie médicale, Hôpital Cochin, AP-HP Centre, Paris, France.
Pascaline Boudou-RouquetteOncologie médicale, Hôpital Cochin, AP-HP Centre, Paris, France.
Camille TlemsaniOncologie médicale, Hôpital Cochin, AP-HP Centre, Paris, France.
Jérôme AlexandreUniversité de Paris, Public Health, Paris, France.
François GoldwasserUniversité de Paris, Public Health, Paris, France.
Pascale VinantUnité Mobile de Soins Palliatifs, Hôpital Cochin, AP-HP Centre, Paris, France.
Hôpital Cochin · FRUniversité Paris Cité · FRUniversité Sorbonne Paris Nord · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPalliative care (PC) referral is recommended early in the course of advanced cancer. This study aims to describe, in an integrated onco-palliative care program (IOPC), patient's profile when first referred to this program, timing of this referral and its impact on the trajectory of care at end-of-life.

methodsThe IOPC combined the weekly onco-palliative meeting (OPM) dedicated to patients with incurable cancer, and/or the clinical evaluation by the PC team. Oncologists can refer to the multidisciplinary board of the OPM the patients for whom goals and organization of care need to be discussed. We analyzed all patients first referred at OPM in 2011-2013. We defined the index of precocity (IP), as the ratio of the time from first referral to death by the time from diagnosis of incurability to death, ranging from 0 (late referral) to 1 (early referral).

resultsOf the 416 patients included, 57% presented with lung, urothelial cancers, or sarcoma. At first referral to IOPC, 76% were receiving antitumoral treatment, 63% were outpatients, 56% had a performance status ≤2 and 46% had a serum albumin level > 35 g/l. The median [1st-3rd quartile] IP was 0.39 [0.16-0.72], ranging between 0.53 [0.20-0.79] (earliest referral, i.e. close to diagnosis of incurability, for lung cancer) to 0.16 [0.07-0.56] (latest referral, i.e. close to death relatively to length of metastatic disease, for prostate cancer). Among 367 decedents, 42 (13%) received antitumoral treatment within 14 days before death, and 157 (43%) died in PC units.

conclusionsThe IOPC is an effective organization to enable early integration of PC and decrease aggressiveness of care near the end-of life. The IP is a useful tool to model the timing of referral to IOPC, while taking into account each cancer types and therapeutic advances.

Indexed as

Decision Making, SharedTime FactorsAgedDelivery of Health Care, IntegratedFemaleHumansMaleMiddle AgedNeoplasmsOncology Service, HospitalPalliative CareReferral and ConsultationRetrospective StudiesTerminal CareAdvanced CancerEnd-of-life careIntegration of oncology and palliative carePalliative careShared decision making

Identifiers

PMID32164672
PMCPMC7069048
OpenAlexW3011408591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.